May Hill Capital
VRTX icon

May Hill Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

May Hill Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$336K Buy
643
+26
+4% +$13.3K 0.07% 174
2026
Q2 		$306K Buy
617
+46
+8% +$20.4K 0.06% 182
2026
Q1 		$255K Sell
571
-95
-14% -$44.3K 0.06% 186
2025
Q4 		$302K Buy
666
+26
+4% +$11.2K 0.08% 150
2025
Q3 		$251K Sell
640
-33
-5% -$13.8K 0.07% 163
2025
Q2 		$300K Buy
673
+40
+6% +$18.4K 0.1% 143
2025
Q1 		$307K Sell
633
-15
-2% -$6.99K 0.12% 122
2024
Q4 		$261K Buy
+648
New +$300K 0.1% 131

Other funds holding VRTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

May Hill Capital's VRTX Position: Q3 2026 in Review

May Hill Capital increased its Vertex Pharmaceuticals (VRTX) stake by 4.2% in Q3 2026, buying an estimated $13.3K and bringing the position to 643 shares worth $336K. The position accounts for 0.07% of the portfolio, ranked #174.

May Hill Capital first reported a position in VRTX in Q4 2024 and has held it in 8 quarters since. 1,083 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • May Hill Capital held 643 shares of Vertex Pharmaceuticals worth $336K as of Q3 2026.
  • May Hill Capital bought 26 Vertex Pharmaceuticals shares in Q3 2026, an estimated $13.3K.
  • Vertex Pharmaceuticals made up 0.07% of May Hill Capital's portfolio in Q3 2026, its #174 holding.
  • May Hill Capital first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • 1,083 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on May Hill Capital's 13F filing for Q3 2026, filed 3 Nov 2026.